One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    AGRICULTURE AND ALLIED ACTIVITIES   >   Eubiotics Market

[ 英語タイトル ] Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, and Essential Oils), Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Global Trends and Forecast to 2020


Product Code : MNMAG0060978
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Agriculture and Allied Activities
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

The eubiotics market in feed has been growing rapidly in the recent years and is projected to reach a market size at USD 7.05 billion by 2020. The market is primarily driven by the growing customer attention towards superior quality feed grades, ban on antibiotics used as growth promoters in the North American and European regions, and for feed supplementation to improve nutrient utilization and nutrient supply to the animals. The consumption of eubiotics is increasing significantly due to various government regulations being adopted to improve animal health.
Europe held the largest share of the eubiotics market in 2014. Currently, the eubiotics market is concentrated more in developed and developing countries, such as U.S., China, India, Japan, Australia, along with European countries. The growth is mainly due to the global increase in meat consumption and rise in concern regarding its quality and safety. The market for probiotics is projected to grow at the highest CAGR of 7.6% during the period from 2015 to 2020. The probiotics segment also accounted for the largest share of 65.47% in 2014, and is projected to be valued at USD 4.69 billion by 2020.
The eubiotics market is highly competitive with a large number of global market players. This report highlights the growth strategies adopted by the major market players between 2010 and 2015. Key industry players invest extensively in research and development initiatives to expand their product portfolios. Continuous investments in new product development, launches, and expansions have expanded the scope of the industry.
The global market is marked with intense competition due to the presence of a large number of big and small firms. New product developments, mergers & acquisitions, and expansions are the key strategies adopted by market players to ensure their growth. The market is dominated by players such as the Chr. Hansen (Denmark), Cargill Incorporated (U.S.) and ADDCON (Germany), BASF SE (Germany), Kemin Industries Inc. (U.S.), and Behn Meyer (Singapore).
In this report, the global eubiotics market is segmented into type, livestock, and region. The said market was valued at USD 4.62 billion in 2014 and is projected to grow at a CAGR of 7.4% from 2015 to 2020.

1.1 AVAILABLE CUSTOMIZATIONS
With the given market data, MarketsandMarkets offers customizations according to the company’s specific scientific needs.

The following customization options are available for the report:

Product Analysis
•Product matrix which gives a detailed comparison of product portfolio of each company

Geographic Analysis
•Further breakdown of the Rest of Asia-Pacific eubiotics market into Malaysia, Thailand, Indonesia, and Vietnam

•Further breakdown of the Rest of RoW eubiotics market into Argentina, Madagascar, Morocco, Chile, Peru, and Sudan

Company Information
•Detailed analyses and profiling of additional market players (up to five)

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 15
1.3 STUDY SCOPE 15
1.3.1 YEARS CONSIDERED 16
1.4 CURRENCY CONSIDERED 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 19
2.1.1.1 Key Data from Secondary Sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key Data from Primary Sources 21
2.1.2.2 Key Industry Insights 22
2.1.2.3 Breakdown of Primary Interviews 23
2.2 FACTOR ANALYSIS 23
2.2.1 INTRODUCTION 23
2.2.2 DEMAND-SIDE ANALYSIS 24
2.2.2.1 Growing population and rising diversified food demand 24
2.2.2.2 Emerging Economies: Population & Meat Demand 25
2.2.3 SUPPLY-SIDE ANALYSIS 25
2.2.3.1 Parent Market Analysis: Animal Feed Industry 25
2.3 MARKET SIZE ESTIMATION 26
2.3.1 BOTTOM-UP APPROACH 27
2.3.2 TOP-DOWN APPROACH 28
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 29
2.5 RESEARCH ASSUMPTIONS & LIMITATIONS 30
2.5.1 ASSUMPTIONS 30
2.5.2 LIMITATIONS 31
3 EXECUTIVE SUMMARY 32

4 PREMIUM INSIGHTS 37
4.1 ATTRACTIVE OPPORTUNITIES IN EUBIOTICS MARKET 37
4.2 PROBIOTICS: LEADING SEGMENT BY TYPE 38
4.3 LEADING MARKET FOR EUBIOTICS 39
4.4 EUROPE: LARGEST EUBIOTICS MARKET 40
4.5 LIFE CYCLE ANALYSIS: BY REGION 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 43
5.1.1 DIFFERENT TYPES OF EUBIOTICS 43
5.1.1.1 Probiotics 43
5.1.1.2 Prebiotics 43
5.1.1.3 Essential oils 43
5.1.1.4 Organic acids 43
5.2 MARKET SEGMENTATION 44
5.2.1 EUBIOTICS MARKET, BY TYPE 44
5.2.2 EUBIOTICS MARKET, BY LIVESTOCK 45
5.3 MARKET DYNAMICS 46
5.3.1 DRIVERS 47
5.3.1.1 Increase in meat production/consumption 47
5.3.1.2 Rising awareness about feed quality 47
5.3.1.3 Increasing disease outbreaks in livestock 48
5.3.1.4 Replacing antibiotic growth promoters (AGP) with eubiotics in feed 48
5.3.2 RESTRAINTS 48
5.3.2.1 Regulatory structure & intervention 48
5.3.3 OPPORTUNITIES 49
5.3.3.1 Investment in research & development 49
5.3.3.2 Exploring regional & untapped markets 49
5.3.4 CHALLENGES 49
5.3.4.1 Rise in Raw Material Prices 49
5.4 REGULATIONS 49
5.4.1 ANTIBITOTICS AS FEED ADDITIVES 49
5.4.2 BAN ON ANTIBIOTICS 50
5.4.2.1 Europe 50
5.4.2.2 South Korea 51
5.4.2.3 U.S. 51
6 INDUSTRY TRENDS 53
6.1 INTRODUCTION 53
6.2 VALUE CHAIN ANALYSIS 53
6.3 SUPPLY CHAIN ANALYSIS 55
6.3.1 PROMINENT COMPANIES 55
6.3.2 SMALL & MEDIUM ENTERPRISES 55
6.3.3 END USERS 56
6.4 PORTER’S FIVE FORCES ANALYSIS 56
6.4.1 INTENSITY OF COMPETITIVE RIVALRY 57
6.4.2 BARGAINING POWER OF SUPPLIERS 57
6.4.3 BARGAINING POWER OF BUYERS 58
6.4.4 THREAT OF NEW ENTRANTS 58
6.4.5 THREAT OF SUBSTITUTES 59
6.5 STRATEGIC BENCHMARKING 60
6.5.1 EXPANSIONS & INVESTMENTS 60
7 EUBIOTICS MARKET, BY TYPE 61
7.1 INTRODUCTION 62
7.2 PROBIOTICS 63
7.2.1 LACTOBACILLI 63
7.2.2 BIFIDOBACTERIA 63
7.3 PREBIOTICS 64
7.3.1 INULIN 64
7.3.2 FRUCTOOLIGOSACCHARIDES (FOS) 64
7.3.3 GALACTO-OLIGOSACCHARIDES (GOS) 64
7.4 ESSENTIAL OILS 66
7.5 ORGANIC ACIDS 67
8 EUBIOTICS MARKET, BY LIVESTOCK 68
8.1 INTRODUCTION 69
8.1.1 KEY FEATURES 69
8.1.1.1 Modulation of microflora 69
8.1.1.2 Stimulate the immune response 69
8.1.1.3 Metabolite excretion 69
8.2 SWINE 71
8.2.1 KEY FEATURES 71
8.2.1.1 Prevent, Stimulate, and Neutralize 71
8.2.1.2 Defence against infection 71
8.3 POULTRY 72
8.3.1 KEY FEATURES 73
8.3.1.1 Growth and improved feed conversion rate 73
8.4 RUMINANTS 74
8.5 AQUATIC ANIMALS 75
8.6 EUBIOTICS FOR OTHER LIVESTOCK TYPES 77
9 EUBIOTICS MARKET, BY REGION 78
9.1 INTRODUCTION 79
9.2 NORTH AMERICA 81
9.2.1 U.S. 84
9.2.2 CANADA 86
9.2.3 MEXICO 87
9.3 EUROPE 89
9.3.1 U.K. 92
9.3.2 GERMANY 94
9.3.3 FRANCE 95
9.3.4 ITALY 97
9.3.5 SPAIN 98
9.3.6 RUSSIA 100
9.3.7 SWITZERLAND 102
9.3.8 REST OF EUROPE 103
9.4 ASIA-PACIFIC 105
9.4.1 CHINA 108
9.4.2 INDIA 110
9.4.3 JAPAN 111
9.4.4 AUSTRALIA 113
9.4.5 REST OF ASIA-PACIFIC 115
9.5 REST OF THE WORLD (ROW) 117
9.5.1 BRAZIL 119
9.5.2 ARGENTINA 121
9.5.3 SOUTH AFRICA 123
9.5.4 OTHER COUNTRIES IN ROW 125
10 COMPETITIVE LANDSCAPE 127
10.1 OVERVIEW 127
10.2 EUBIOTICS MARKET: MARKET SHARE ANALYSIS (DEVELOPMENTS) 128
10.3 COMPETITIVE SITUATIONS & TRENDS 129
10.3.1 EXPANSIONS & INVESTMENTS 130
10.3.2 MERGERS & ACQUISITIONS 131
10.3.3 AGREEMENTS, PARTNERSHIPS, JOINT VENTURES & COLLABORATIONS 132
10.3.4 NEW PRODUCT LAUNCHES 133
10.3.5 INNOVATION 133

11 COMPANY PROFILES 134
(Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
11.1 INTRODUCTION 134
11.2 CHR. HANSEN A/S 135
11.3 ROYAL DSM 139
11.4 E. I. DU PONT DE NEMOURS AND COMPANY 143
11.5 CARGILL INCORPORATED 146
11.6 KEMIN INDUSTRIES INC. 149
11.7 BASF SE 152
11.8 BEHN MEYER GROUP 156
11.9 BENEO GROUP 158
11.10 NOVUS INTERNATIONAL, INC. 159
11.11 ADDCON 161
*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.
12 APPENDIX 163
12.1 INSIGHTS OF INDUSTRY EXPERTS 163
12.2 DISCUSSION GUIDE 164
12.3 COMPANY DEVELOPMENTS 167
12.3.1 NEW PRODUCT LAUNCHES/DEVELOPMENTS 167
12.3.2 MERGERS & ACQUISITIONS 168
12.3.3 EXPANSIONS & INVESTMENTS 169
12.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 170
12.5 AVAILABLE CUSTOMIZATIONS 170
12.6 RELATED REPORTS 171
LIST OF TABLES

TABLE 1 PER CAPITA CONSUMPTION OF MEAT 47
TABLE 2 EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 62
TABLE 3 PROBIOTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 64
TABLE 4 PREBIOTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 65
TABLE 5 ESSENTIAL OILS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 66
TABLE 6 ORGANIC ACIDS MARKET SIZE, BY REGION,2013-2020 (USD MILLION) 67
TABLE 7 EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 70
TABLE 8 GLOBAL MEAT PRODUCTION MARKET SIZE, BY MEAT TYPE, 2013–2020 (KT) 70
TABLE 9 PER CAPITA PORK CONSUMPTION, BY KEY COUNTRY/REGION,
2013–2020 (KG/YEAR) 71
TABLE 10 SWINE: EUBIOTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 72
TABLE 11 PER CAPITA POULTRY CONSUMPTION, BY KEY COUNTRY/REGION,
2013-2020(KG/YEAR) 73
TABLE 12 POULTRY: EUBIOTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 73
TABLE 13 PER CAPITA BEEF CONSUMPTION, BY KEY COUNTRY/REGION,
2013–2020 (KG/YEAR) 74
TABLE 14 RUMINANTS: EUBIOTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 75
TABLE 15 PER CAPITA FISH CONSUMPTION, BY KEY COUNTRY, 2013-2014 (KG/YEAR) 76
TABLE 16 AQUATIC ANIMALS: EUBIOTICS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 76
TABLE 17 OTHER LIVESTOCK EUBIOTICS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 77
TABLE 18 EUBIOTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 80
TABLE 19 NORTH AMERICA: EUBIOTICS MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 83
TABLE 20 NORTH AMERICA: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 83
TABLE 21 NORTH AMERICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK,
2013–2020 (USD MILLION) 84
TABLE 22 U.S.: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 85
TABLE 23 U.S.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 85
TABLE 24 CANADA: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 86
TABLE 25 CANADA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 87
TABLE 26 MEXICO: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 88
TABLE 27 MEXICO: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 88
TABLE 28 EUROPE: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 91
TABLE 29 EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 91
TABLE 30 EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 92
TABLE 31 U.K.: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 93
TABLE 32 U.K.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 93
TABLE 33 GERMANY: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 94

TABLE 34 GERMANY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 95
TABLE 35 FRANCE: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 96
TABLE 36 FRANCE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 96
TABLE 37 ITALY: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 97
TABLE 38 ITALY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 98
TABLE 39 SPAIN: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 98
TABLE 40 SPAIN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 99
TABLE 41 RUSSIA: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 100
TABLE 42 RUSSIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 101
TABLE 43 SWITZERLAND: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 102
TABLE 44 SWITZERLAND: EUBIOTICS MARKET SIZE, BY LIVESTOCK,
2013–2020 (USD MILLION) 103
TABLE 45 REST OF EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 104
TABLE 46 REST OF EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK,
2013–2020 (USD MILLION) 104
TABLE 47 ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 107
TABLE 48 ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 107
TABLE 49 ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK,
2013–2020 (USD MILLION) 108
TABLE 50 CHINA: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 109
TABLE 51 CHINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 109
TABLE 52 INDIA: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 110
TABLE 53 INDIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 111
TABLE 54 JAPAN: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 112
TABLE 55 JAPAN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 112
TABLE 56 AUSTRALIA: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 113
TABLE 57 AUSTRALIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 114
TABLE 58 REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE,
2013–2020 (USD MILLION) 115
TABLE 59 REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK,
2013–2020 (USD MILLION) 116
TABLE 60 ROW: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 117
TABLE 61 ROW: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 118
TABLE 62 ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 118
TABLE 63 BRAZIL: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 119
TABLE 64 BRAZIL: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 120
TABLE 65 ARGENTINA: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 121
TABLE 66 ARGENTINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013–2020 (USD MILLION) 122
TABLE 67 SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 123
TABLE 68 SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK,
2013–2020 (USD MILLION) 124

TABLE 69 OTHERS COUNTRIES IN ROW: EUBIOTICS MARKET SIZE, BY TYPE,
2013–2020 (USD MILLION) 125
TABLE 70 OTHERS COUNTRIES IN ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK,
2013–2020 (USD MILLION) 126
TABLE 71 EXPANSIONS & INVESTMENTS, 2010–2015 130
TABLE 72 MERGERS & ACQUISITIONS, 2010–2015 131
TABLE 73 AGREEMENTS, PARTNERSHIPS, JOINT VENTURES & COLLABORATIONS,
2010–2015 132
TABLE 74 NEW PRODUCT LAUNCHES, 2010–2015 133
TABLE 75 BASF SE: PRODUCTS & THEIR DESCRIPTION 153
LIST OF FIGURES

FIGURE 1 EUBIOTICSMARKET SEGMENTATION 15
FIGURE 2 RESEARCH DESIGN 19
FIGURE 3 POPULATION GROWTH TREND, 1961-2050 24
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 27
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 28
FIGURE 6 DATA TRIANGULATION 29
FIGURE 7 EUBIOTICS MARKET SNAPSHOT, BY LIVESTOCK (2015 VS. 2020) 33
FIGURE 8 EUBIOTICS MARKET SIZE, BY REGION, 2015–2020 (USD MILLION) 34
FIGURE 9 EUBIOTICS MARKET SIZE, BY TYPE, 2015–2020 USD (USD MILLION) 35
FIGURE 10 EUBIOTICS MARKET SHARE (VALUE), BY REGION, 2014 36
FIGURE 11 GROWTH IN EUBIOTICS MARKET 37
FIGURE 12 PROBIOTICS PROJECTED TO BE THE LARGEST SEGMENT 38
FIGURE 13 U.S.: LARGEST MARKET FOR EUBIOTICS (2015-2020) 39
FIGURE 14 PROBIOTICS SEGMENT ACCOUNTED FOR LARGEST SHARE IN THE EUROPEAN EUBIOTICS MARKET, 2014 40
FIGURE 15 ASIA-PACIFIC REGION TO PROVIDE IMMENSE POTENTIAL OPPORTUNITIES FOR EUBIOTICS MARKET GROWTH 41
FIGURE 16 EUBIOTICS MARKET, BY TYPE 44
FIGURE 17 EUBIOTICS MARKET, BY LIVESTOCK 45
FIGURE 18 INCREASE IN MEAT PRODUCTION/CONSUMPTION DRIVING THE GROWTH OF EUBIOTICS MARKET 46
FIGURE 19 R&D CONTRIBUTES MAJOR VALUE TO OVERALL PRICE OF EUBIOTICS MARKET 54
FIGURE 20 RESEARCH ORGANIZATIONS & TECHNOLOGISTS: INTEGRAL PART OF SUPPLY CHAIN OF EUBIOTICS MARKET 55
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS: EUBIOTICS MARKET 56
FIGURE 22 STRATEGIC BENCHMARKING: EXPANSIONS & INVESTMENTS 60
FIGURE 23 PROBIOTICS IS THE FASTEST GROWING SEGMENT IN EUBIOTICS MARKET 62
FIGURE 24 EUROPE IS PROJECTED TO LEAD THE PREBIOTICS MARKET IN 2020 65
FIGURE 25 EUBIOTICS MARKET SHARE (VALUE), BY LIVESTOCK, 2015-2020 69
FIGURE 26 GEOGRAPHIC SNAPSHOT (2015–2020): RAPIDLY GROWING MARKETS ARE EMERGING AS NEW HOTSPOTS 80
FIGURE 27 NORTH AMERICAN EUBIOTICS MARKET: A SNAPSHOT, 2014 82
FIGURE 28 EUROPEAN EUBIOTICS MARKET: A SNAPSHOT, 2014 90
FIGURE 29 CHINA WAS THE MARKET LEADER IN THE ASIA-PACIFIC REGION IN 2014 106
FIGURE 30 EXPANSIONS AND INVESTMENTS: LEADING APPROACH OF KEY PLAYERS 127
FIGURE 31 EUBIOTICS MARKET SHARE (DEVELOPMENTS), BY COMPANY, 2010–2015 128
FIGURE 32 EXPANSIONS, INVESTMENTS, FUELED GROWTH OF EUBIOTICS MARKET BETWEEN 2010 TO 2015 129
FIGURE 33 EXPANSIONS AND INVESTMENTS: THE KEY STRATEGY, 2010-2015 130

FIGURE 34 GEOGRAPHICAL REVENUE MIX OF TOP 5 MARKET PLAYERS 134
FIGURE 35 CHR. HANSEN A/S: COMPANY SNAPSHOT 136
FIGURE 36 CHR. HANSEN A/S: SWOT ANALYSIS 138
FIGURE 37 ROYAL DSM : COMPANY SNAPSHOT 140
FIGURE 38 DSM N. V.: SWOT ANALYSIS 142
FIGURE 39 E. I. DU PONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT 143
FIGURE 40 E. I. DU PONT DE NEMOURS AND COMPANY: SWOT ANALYSIS 145
FIGURE 41 CARGILL INCORPORATED: COMPANY SNAPSHOT 146
FIGURE 42 CARGILL INCORPORATED: SWOT ANALYSIS 148
FIGURE 43 KEMIN INDUSTRIES INC.: SWOT ANALYSIS 151
FIGURE 44 BASF SE: COMPANY SNAPSHOT 153
FIGURE 45 BASF SE: SWOT ANALYSIS 154

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+